Sarduy NM

Language: Spanish
References: 13
Page:
PDF size: 58.25 Kb.

ABSTRACT

The malignancy of the cervix is †one of the few locations avoidable cancers, if detected before it progresses to the infiltration. The most efficient way of early detection is through a screening program to provide women undertaking a regular and quality Pap smear. If this test results abnormal, the program offers easier access to specialized care, effective treatment, and follow-up. The objective of this article is to present usefulness of methods for quality control used in screening programs for cervical cancer to detect their inadequacies. Here are some factors and conditions that must be considered in each of the steps to take, for a cervical cancer screening program to be successful and to meet the objectives proposed in reducing mortality due to this cause. This document contains some useful indexes calculated to ensure quality throughout the process. There should be the measurement of quality throughout the screening process that allows collecting of reliable data as well as correcting deficiencies.

REFERENCES

1. Sarduy Nápoles M. Evaluación de tres métodos de tratamiento conservador de la Neoplasia Intraepitelial cervical [tesis doctoral]. La Habana: Centro de Investigaciones Médico Quirúrgicas (CIMEQ); 2006.

2. Anuario estadístico de salud. Ministerio de Salud Pública. Dirección Nacional de Registros médicos y estadísticas de salud. La Habana: MINSAP; 2010. p. 81.

3. De Palo G, Chanen W, Dexeus S. Neoplasia intraepitelial cervical. En: Patología y tratamiento del tracto genital inferior. Barcelona: Editorial Masson; 2001. p. 62- 89.

4. Goldie Sj, Kuhn L, Denny L. Policy analysis of cervical cancer screening strategies in low ewaourxe setting: clinical benefits and cost effectiveness. JAMA. 2001;285:3107-15.

5. Papanicolaou G, Trout HF. Diagnosis of uterine cancer by cervical smear. London, Oxford and New York: The Commonwealth Fund; 1943.

6. Lara E. Day EN, Hakama M. Trenes in mortality from cervical cancer in the nordic countries: association with organizes screening programes. Lancet. 1987:1247-9.

7. Millar AB. Cervical screening programes, Geneva: World Health Organization; 1992.

8. Colectivo de autores. Programa Nacional de Diagnóstico Precoz del Cáncer Cérvicouterino. La Habana: MINSAP; 2001.

9. Colectivo de autores. Revisión del Programa Nacional de Diagnóstico Precoz del Cáncer Cérvicouterino. Unidad independiente para el control del cáncer. La Habana: MINSAP. En prensa 2011.

10. Montes E. Control de calidad en los laboratorios involucrados en los programas de detección del cáncer cérvicouterino. En: Alonso P, Lazcano E, Hernández M (eds). Cáncer cérvicouterino. Diagnóstico, prevención y control. México D.F: Edit. Médica Panamericana. 2da. ed; 2005. p. 115-21.

11. Programa Nacional de Cáncer. Estrategias para reducir la mortalidad. La Habana: MINSAP; 2007.

12. Lörincz A. Estudios para la detección del cáncer cérvicouterino. En: Cáncer cérvicouterino. Diagnóstico, prevención y control. México D.F: Ed. Médica Panamericana; 2005. p. 263-276.

13. Austin RM. Results of blinded rescreening of Papanicolau smears versus blased retrospective review. Arch Pathol Lab Med. 1997;121:311-4.